SOLIFENACIN AMEDA, VESICAN, SOLIFENACIN GENERICHEALTH, SEFICARE, SOLIFENACIN INTAS (Accord Healthcare Pty Ltd)
Product name
SOLIFENACIN AMEDA, VESICAN, SOLIFENACIN GENERICHEALTH, SEFICARE, SOLIFENACIN INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
212 working days (255)
Active ingredients
solifenacin succinate
Registration type
New generic medicine
Indication
SOLIFENACIN AMEDA, VESICAN, SOLIFENACIN GENERICHEALTH, SEFICARE, SOLIFENACIN INTAS (film-coated tablets) are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.